• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

表面改性聚(丙交酯-乙交酯)纳米颗粒作为氟他胺控释载体的制备及其体外-体内评价

Preparation and in vitro-in vivo evaluation of surface-modified poly(lactide-co-glycolide) nanoparticles as controlled release carriers for flutamide delivery.

作者信息

Ige Pradum Pundlikrao, Dipsingh Solanki Nirmal

机构信息

Department of Pharmaceutics and Quality Assurance, R C Patel Institute of Pharmaceutical Education and Research , Shirpur, Dhule, Maharashtra , India.

出版信息

J Microencapsul. 2015;32(3):231-9. doi: 10.3109/02652048.2014.995731. Epub 2014 Dec 24.

DOI:10.3109/02652048.2014.995731
PMID:25539154
Abstract

This investigation explores the use of methoxy polyethylene glycol (mPEG) functionalised poly(D,L-lactide-co-glycolide) (PLGA) nanocrystals of flutamide (FLT) with enhanced solubility, bioavailability and blood circulation time for targeting prostate cancer. FLT had Log P 3.27, short half life 5-6 h, low water solubility, permeability and bioavailability with extensive first-pass metabolism. FLT-loaded nanocrystals were prepared using nanoprecipitation method with surface coating by mPEG and characterised through differential scanning calorimetry, Fourier transform infrared spectroscopy, X-ray powder diffraction, scanning electronic microscopy, particle size, zeta potential, percent entrapment efficiency (% EE), in vitro dissolution, haemolysis, sterility, bioavailability and stability studies. The percent cumulative drug release and % EE of optimised formulation was found to be 95.21 ± 1.18 and 88.36 ± 1.20, respectively, for 48 h. In addition, FLT-loaded PEGylated PLGA nanocrystals exhibited significantly delayed blood clearance with drug level of about 766.71 ng/mL at 48 h. In conclusion, PEGylated PLGA FLT nanocrystals could be demonstrated as a novel approach to enhance solubility, bioavailability and blood circulation time.

摘要

本研究探索了用甲氧基聚乙二醇(mPEG)功能化的聚(D,L-丙交酯-共-乙交酯)(PLGA)纳米晶体包裹氟他胺(FLT),以提高其溶解度、生物利用度和血液循环时间,从而靶向治疗前列腺癌。氟他胺的脂水分配系数(Log P)为3.27,半衰期短(5 - 6小时),水溶性低,渗透性和生物利用度低,且存在广泛的首过代谢。采用纳米沉淀法制备了负载氟他胺的纳米晶体,并通过mPEG进行表面包覆,通过差示扫描量热法、傅里叶变换红外光谱法、X射线粉末衍射法、扫描电子显微镜、粒径、zeta电位、包封率(% EE)、体外溶出度、溶血、无菌性、生物利用度和稳定性研究对其进行了表征。优化制剂的累积药物释放百分比和包封率在48小时内分别为95.21 ± 1.18和88.36 ± 1.20。此外,负载氟他胺的聚乙二醇化PLGA纳米晶体的血液清除明显延迟,48小时时药物水平约为766.71 ng/mL。总之,聚乙二醇化PLGA氟他胺纳米晶体可被证明是一种提高溶解度、生物利用度和血液循环时间的新方法。

相似文献

1
Preparation and in vitro-in vivo evaluation of surface-modified poly(lactide-co-glycolide) nanoparticles as controlled release carriers for flutamide delivery.表面改性聚(丙交酯-乙交酯)纳米颗粒作为氟他胺控释载体的制备及其体外-体内评价
J Microencapsul. 2015;32(3):231-9. doi: 10.3109/02652048.2014.995731. Epub 2014 Dec 24.
2
Andrographolide-loaded PLGA-PEG-PLGA micelles to improve its bioavailability and anticancer efficacy.载有穿心莲内酯的 PLGA-PEG-PLGA 胶束以提高其生物利用度和抗癌功效。
Expert Opin Drug Deliv. 2014 Sep;11(9):1367-80. doi: 10.1517/17425247.2014.924503. Epub 2014 Jun 16.
3
Lyophilization monophase solution technique for preparation of amorphous flutamide dispersions.冷冻干燥单相溶液技术制备无定形氟他胺分散体。
Drug Dev Ind Pharm. 2011 Jul;37(7):754-64. doi: 10.3109/03639045.2010.539232. Epub 2011 Jan 5.
4
Small angle neutron scattering studies on the internal structure of poly(lactide-co-glycolide)-block-poly(ethylene glycol) nanoparticles as drug delivery vehicles.聚(丙交酯-乙交酯)-嵌段-聚乙二醇纳米颗粒作为药物递送载体的内部结构的小角中子散射研究
Biomacromolecules. 2015 Feb 9;16(2):457-64. doi: 10.1021/bm501519u. Epub 2015 Jan 14.
5
Hydroxypropyl-beta-cyclodextrin-flutamide inclusion complex. II. Oral and intravenous pharmacokinetics of flutamide in the rat.羟丙基-β-环糊精-氟他胺包合物。II. 氟他胺在大鼠体内的口服及静脉药代动力学
J Pharm Pharm Sci. 2002 Sep-Dec;5(3):292-8.
6
Poly(lactide-co-glycolide)-methoxy-poly(ethylene glycol) nanoparticles: drug loading and release properties.聚(丙交酯-乙交酯)-甲氧基聚(乙二醇)纳米颗粒:载药及释药特性
J Nanosci Nanotechnol. 2006 Sep-Oct;6(9-10):3080-6. doi: 10.1166/jnn.2006.404.
7
Tumor necrosis factor alpha blocking peptide loaded PEG-PLGA nanoparticles: preparation and in vitro evaluation.负载肿瘤坏死因子α阻断肽的聚乙二醇-聚乳酸-羟基乙酸共聚物纳米粒:制备及体外评价
Int J Pharm. 2007 Feb 22;331(1):123-32. doi: 10.1016/j.ijpharm.2006.09.015. Epub 2006 Sep 17.
8
Preparation and evaluation of tacrolimus-loaded nanoparticles for lymphatic delivery.载他克莫司纳米粒的制备及淋巴递药评价。
Eur J Pharm Biopharm. 2010 Feb;74(2):164-71. doi: 10.1016/j.ejpb.2009.08.006. Epub 2009 Aug 22.
9
Long circulating PEGylated PLGA nanoparticles of cytarabine for targeting leukemia.阿糖胞苷长循环聚乙二醇化 PLGA 纳米粒用于靶向白血病。
J Microencapsul. 2011;28(8):729-42. doi: 10.3109/02652048.2011.615949. Epub 2011 Oct 4.
10
Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin.透明质酸锚定的阿霉素聚乳酸-羟基乙酸共聚物纳米颗粒载体的研制与表征
Nanomedicine. 2007 Dec;3(4):246-57. doi: 10.1016/j.nano.2007.09.004.

引用本文的文献

1
Pharmaceutical Approach to Develop Novel Photosensitizer Nanoformulation: An Example of Design and Characterization Rationale of Chlorophyll α Derivative.开发新型光敏剂纳米制剂的药学方法:以叶绿素α衍生物的设计与表征原理为例
Pharmaceutics. 2024 Jan 18;16(1):126. doi: 10.3390/pharmaceutics16010126.
2
A comparison of models for the analysis of the kinetics of drug release from PLGA-based nanoparticles.基于聚乳酸-羟基乙酸共聚物(PLGA)的纳米颗粒药物释放动力学分析模型的比较
Heliyon. 2020 Feb 28;6(2):e03451. doi: 10.1016/j.heliyon.2020.e03451. eCollection 2020 Feb.